InVivo Therapeutics Holdings Co (NVIVQ)
Jul 16, 2024 - NVIVQ was delisted (reason: shares cancelled)
0.370
0.00 (0.00%)
Last trade price

NVIVQ Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018 2017 - 2009
Net Income
-9.33-10.49-9.9-9.07-11.83-23.42
Upgrade
Depreciation & Amortization
0.420.450.370.330.320.09
Upgrade
Share-Based Compensation
0.190.160.320.220.270.62
Upgrade
Other Operating Activities
-1.41-0.60.35-10.9310.4
Upgrade
Operating Cash Flow
-10.13-10.48-8.85-9.53-10.31-12.31
Upgrade
Capital Expenditures
0.05-0.16-0.08-0.04-0.01-0.07
Upgrade
Investing Cash Flow
0.05-0.16-0.08-0.04-0.01-0.07
Upgrade
Share Issuance / Repurchase
7.967.968.5122.460.3716.65
Upgrade
Debt Issued / Paid
0000-0.1-0.75
Upgrade
Other Financing Activities
------0.01
Upgrade
Financing Cash Flow
7.967.968.5122.460.2715.88
Upgrade
Net Cash Flow
-2.12-2.68-0.4212.89-10.063.5
Upgrade
Free Cash Flow
-10.08-10.64-8.93-9.58-10.33-12.38
Upgrade
Free Cash Flow Per Share
-3.25-6.93-6.75-34.68-769.79-1860.11
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).